Impact of Alu repeats on the evolution of human p53 binding sites

Biology Direct

Volumn 6, Issue , 2011, Pages

  Cui, Feng ^a   Sirotin, Michael V ^a   Zhurkin, Victor B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMATES;

DNA; PROTEIN P53; SPACER DNA;

ALU SEQUENCE; ARTICLE; BINDING SITE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; CHROMATIN; CONFORMATION; DNA RESPONSIVE ELEMENT; GENETICS; HUMAN; HUMAN GENOME; METABOLISM; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT;

ALU ELEMENTS; BASE SEQUENCE; BINDING SITES; CHROMATIN; COMPUTATIONAL BIOLOGY; DNA; DNA, INTERGENIC; EVOLUTION, MOLECULAR; GENOME, HUMAN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RESPONSE ELEMENTS; SEQUENCE ALIGNMENT; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78650855113     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/1745-6150-6-2     Document Type: Article

References (82)

1. Toledo F, Wahl GM. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006, 6(12):909-923. 10.1038/nrc2012, 17128209.
2. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleder R, Jacks T. Restoration of p53 function leads to tumour regression in vivo. Nature 2007, 445(7128):661-665. 10.1038/nature05541, 17251932.
3. Staples OD, Steele RJ, Lain S. p53 as a therapeutic target. Surgeon 2008, 6(4):240-243. 10.1016/S1479-666X(08)80034-0, 18697367.
4. Staib F, Robles AI, Varticovski L, Wang XW, Zeeberg BR, Sirotin M, Zhurkin VB, Hofseth LJ, Hussain SP, Weinstein JN, Galle PR, Harris CC. The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res 2005, 65(22):10255-10264. 10.1158/0008-5472.CAN-05-1714, 1421332, 16288013.
5. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1992, 1(1):45-49. 10.1038/ng0492-45, 1301998.
6. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008, 9(5):402-412. 10.1038/nrm2395, 18431400.
7. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, Liu J, Zhao XD, Chew JL, Lee YL, Kuznetsov VA, Sung WK, Miller LD, Lim B, Liu ET, Yu Q, Ng HH, Ruan Y. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006, 124(1):207-219. 10.1016/j.cell.2005.10.043, 16413492.
8. Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJJ, Akkers RC, Denissov S, Stunnenberg HG, Lohrum M. Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 2008, 36(11):3639-3654. 10.1093/nar/gkn232, 2441782, 18474530.
9. Mirza A, Wu Q, Wang L, McClanahan T, Bishop WR, Gheyas F, Ding W, Hutchins B, Hockenberry T, Kirschmeier P, Greene JR, Liu S. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene 2003, 22(23):3645-3654. 10.1038/sj.onc.1206477, 12789273.
10. Espinosa JM, Emerson BM. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 2001, 8(1):57-69. 10.1016/S1097-2765(01)00283-0, 11511360.
11. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 2002, 277(5):3247-3257. 10.1074/jbc.M106643200, 11714700.
12. Zhurkin VB, Sirotin M, Robles A, Rauf K, Jernigan RL, Zhurkin M. Distribution of p53 sites in the human genome reflects the versatility of p53 binding and its tumor suppressor functions. J Biomol Struct Dynam 2003, 20(6):858-859.
13. Sirotin M, Cui F, Zhurkin VB. The tumor suppressor protein p53 binding sites in the human genome: How are they related to transposons?. Genomic Impact of Eukaryotic Transposable Elements, 1st International Conference/Worskshop 31 March - 4 April 2006 Asilomar 2006, 46.
14. Wang T, Zeng J, Lowe CB, Sellers RG, Salama SR, Yang M, Burgess SM, Brachmann RK, Haussler D. Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53. Proc Natl Acad Sci USA 2007, 104(47):18613-18618. 10.1073/pnas.0703637104, 2141825, 18003932.
15. Cui F, Sirotin MV, Zhurkin VB. The tumor suppressor protein p53 binding sites in mammalian genomes are related to transposons. Genomic Impact of Eukaryotic Transposable Elements, 2nd International Conference/Workshop 6-10 February 2009 Asilomar 2009, 36.
16. Lander ES, et al. Initial sequencing and analysis of the human genome. Nature 2001, 409(6822):860-921. 10.1038/35057062, 11237011.
17. Jordan IK, Rogozin IB, Glazko GV, Koonin EV. Origin of a substantial fraction of human regulatory sequences from transposable elements. Trends Genet 2003, 19(2):68-72. 10.1016/S0168-9525(02)00006-9, 12547512.
18. Medstrand P, van de Lagemaat LN, Dunn CA, Landry JR, Svenback D, Mager DL. Impact of transposable elements on the evolution of mammalian gene regulation. Cytogenet Genome Res 2005, 110(1-4):342-352. 10.1159/000084966, 16093686.
19. Feschotte C. Transposable elements and the evolution of regulatory networks. Nat Rev Genet 2009, 9(5):397-405.
20. Britten RJ, Davidson EH. Gene regulation for higher cells: a theory. Science 1969, 165(891):349-357. 10.1126/science.165.3891.349, 5789433.
21. Kim JH, Yu CY, Bailey A, Hardison R, Shen CKJ. Unique sequence organization and erythroid cell-specific nuclear factor-binding of mammalian θ1 globin promoters. Nucleic Acids Res 1989, 17(14):5687-5700. 10.1093/nar/17.14.5687, 318189, 2569721.
22. Kato N, Shimotohno K, vanLeeuwen D, Cohen M. Human proviral mRNAs down regulated in choriocarcinoma encode a Zinc finger protein related to Kruüppel. Mol Cell Biol 1990, 10(8):4401-4405. 361000, 2115127.
23. Wu J, Grindlay GJ, Bushel P, Mendelsohn L, Allan M. Negative regulation of the human ε-globin gene by transcriptional interference: role of an Alu repetitive element. Mol Cell Biol 1990, 10(3):1209-1216.
24. Neznanov N, Thorey IS, Cecena G, Oshima RG. Transcriptional insulation of the human keratin 18 gene in transgenic mice. Mol Cell Biol 1993, 13(4):2214-2223. 359542, 7681143.
25. Brini AT, Lee GM, Kinet JP. Transcriptional insulation of the human keratin 18 gene in transgenic mice. J Biol Chem 1993, 268(2):1355-1361.
26. Morzycka-Wroblewska E, Harwood JI, Smith JR, Kagnoff MF. Structure and evolution of the promoter regions of the DQA genes. Immunogenetics 1993, 37(5):364-372. 10.1007/BF00216801, 8428769.
27. Hanke JH, Hambor JE, Kavathas P. Repetitive Alu elements form a cruciform structure that regulates the function of the human CD8α T cell-specific enhancer. J Mol Biol 1995, 246(1):63-73. 10.1006/jmbi.1994.0066, 7853405.
28. Hamdi HK, Nishio H, Tavis J, Zielinski R, Dugaiczyk A. Alu-mediated phylogenetic novelties in gene regulation and development. J Mol Biol 2000, 299(4):931-939. 10.1006/jmbi.2000.3795, 10843848.
29. Norris J, Fan D, Aleman C, Marks JR, Futreal A, Wiseman RW, Iglehart JD, Deininger PL, McDonnell DP. Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem 1995, 270(39):22777-22782. 10.1074/jbc.270.39.22777, 7559405.
30. Le Goff W, Guerin M, Chapman MJ, Thillet JA. CYP7A promoter binding factor site and Alu repeat in the distal promoter region are implicated in regulation of human CETP gene expression. J Lipid Res 2003, 44(7):902-910. 10.1194/jlr.M200423-JLR200, 12588948.
31. Hambor JE, Mennone J, Coon ME, Hanke JH, Kavathas P. Identification and characterization of an Alu-containing T-cell-specific enhancer located in the last intron of the human CD8α gene. Mol Cell Biol 1993, 13(11):7056-7070. 364767, 8413295.
32. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite Sp1-thyroid hormone-retinoic acid response element. J Biol Chem 1996, 271(24):14412-14420. 10.1074/jbc.271.24.14412, 8662930.
33. Oei SL, Babich VS, Kazakov VI, Usmanova NM, Kropotov A, Tomilin NV. Clusters of regulatory signals for RNA polymerase II transcription associated with Alu family repeats and CpG islands in human promoters. Genomics 2004, 83(5):873-882. 10.1016/j.ygeno.2003.11.001, 15081116.
34. Humphrey GW, Englander EW, Howard BH. Specific binding sites for a pol III transcriptional repressor and pol II transcription factor YY1 within the internucleosomal spacer region in primate Alu repetitive elements. Gene Expr 1996, 6(3):151-168.
35. Vansant G, Reynolds WF. The consensus sequence of a major Alu subfamily contains a functional retinoic acid response element. Proc Natl Acad Sci USA 1995, 92(18):8229-8233. 10.1073/pnas.92.18.8229, 41130, 7667273.
36. Zemojtel T, Kielbasa SM, Arndt PF, Chung H-R, Vingron M. Methylation and deamination of CpGs generate p53-binding sites on a genomic scale. Trends Genet 2009, 25(2):63-66. Genomic Impact of Eukaryotic Transposable Elements, 2nd International Conference/Workshop: 6-10 February 2009; Asilomar. 2009:37., 10.1016/j.tig.2008.11.005, 19101055.
37. Englander EW, Howard BH. Nucleosome positioning by human Alu elements in chromatin. J Biol Chem 1995, 270(17):10091-10096. 10.1074/jbc.270.17.10091, 7730313.
38. Englander EW, Wolffe AP, Howard BH. Nucleosome Interactions with a human Alu element. J Biol Chem 1993, 268(26):19565-19573.
39. Sahu G, Wang D, Chen CB, Zhurkin VB, Harrington RE, Appella E, Hager GL, Nagaich AK. P53 binding to nucleosomal DNA depends on the rotational positioning of DNA response element. J Biol Chem 2010, 285(2):1321-1332. 10.1074/jbc.M109.081182, 2801259, 19887449.
40. Polak P, Domany E. Alu elements contain many binding sites for transcription factors and may play a role in regulation of developmental processes. BMC Genomics 2006, 7:133. 10.1186/1471-2164-7-133, 1513395, 16740159.
41. Mori T, Anazawa Y, Matsui K, Fukuda S, Nakamura Y, Arakawa H. Cyclin K as a direct transcriptional target of the p53 tumor suppressor. Neoplasia 2002, 4(3):268-274. 10.1038/sj.neo.7900235, 1531701, 11988847.
42. Wu M, Xu LG, Su T, Tian Y, Zhai Z, Shu HB. AMID is a p53-inducible gene downregulated in tumors. Oncogene 2004, 23(40):6815-6819. 10.1038/sj.onc.1207909, 15273740.
43. Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y, Monden M, Nakamura Y. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell 2001, 8(1):85-94. 10.1016/S1097-2765(01)00284-2, 11511362.
44. Tanaka Y, Yamashita R, Suzuki Y, Nakai K. Effects of Alu elements on global nucleosome positioning in the human genome. BMC Genomics 2010, 11(309). 2878307, 20478020.
45. Durell SR, Jernigan RL, Appella E, Nagaich AK, Harrington RE, Zhurkin VB. DNA bending induced by tetrameric binding of the p53 tumor suppressor protein: steric constraints on conformation. Structure, Motion, Interaction and Expression of Biological Macromolecules 1998, 277-295. New York: Academic Press, Sarma RH, Sarma MH.
46. Nagaich AK, Zhurkin VB, Durell SR, Jernigan RL, Appella E, Harrington RE. p53-induced DNA bending and twisting: p53 tetramer binds on the outer side of a DNA loop and increases DNA twisting. Proc Natl Acad Sci USA 1999, 96:1875-1880. 10.1073/pnas.96.5.1875, 26704, 10051562.
47. Cui F, Zhurkin VB. Structure-based analysis of DNA sequence patterns guiding nucleosome positioning in vitro. J Biomol Str Dynam 2010, 27:821-841.
48. Kaneshiro K, Tsutsumi S, Tsuji S, Shirahige K, Aburatani H. An integrated map of p53-bindings sites and histone modification in the human ENCODE regions. Genomics 2007, 89(2):178-188. 10.1016/j.ygeno.2006.09.001, 17085012.
49. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ, Wheeler R, Wong B, Drenkow J, Yamanaka M, Patel S, Brubaker S, Tammana H, Helt G, Struhl K, Gingeras. Unbiased mapping of transcription factor binding sites along human chromosome 21 and 22 points to widespread regulation of noncoding RNAs. Cell 2004, 116(4):499-509. 10.1016/S0092-8674(04)00127-8, 14980218.
50. Veprintsev DB, Fersht AR. Algorithm for prediction of tumor suppressor p53 affinity for binding sites in DNA. Nucleic Acids Res 2008, 36(5):1589-1598. 10.1093/nar/gkm1040, 2275157, 18234719.
51. Chesnokov I, Chu W, Botchan MR, Schmid CW. p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner. Mol Cell Biol 1996, 16(12):7084-7088. 231711, 8943363.
52. Cairns CA, White RJ. p53 is a general repressor of RNA polymerase III transcription. EMBO J 1998, 17(11):3112-3123. 10.1093/emboj/17.11.3112, 1170650, 9606193.
53. Crighton D, Woiwode A, Zhang C, Mandavia N, Morton JP, Warnock LJ, Milner J, White RJ, Johnson DL. p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. EMBO J 2003, 22(11):2810-2820. 10.1093/emboj/cdg265, 156762, 12773395.
54. Stein T, Crighton D, Warnock LJ, Milner J, White RJ. Several regions of p53 are involved in repression of RNA polymerase III transcription. Oncogene 2002, 21(36):5540-5547. 10.1038/sj.onc.1205739, 12165852.
55. White RJ. RNA polymerase III transcription and cancer. Oncogene 2004, 23(18):3208-3216. 10.1038/sj.onc.1207547, 15094770.
56. Tang R-B, Wang H-Y, Lu H-Y, Xiong J, Li H-H, Qiu X-H, Liu H-Q. Increased Level of Polymerase III Transcribed Alu RNA in Hepatocellular Carcinoma Tissue. Mol Carcinogenesis 2005, 42(2):93-96.
57. Liu B, Alberts BM. Head-on collision between a DNA replication apparatus and RNA polymerase transcription complex. Science 1995, 267(5201):1131-1137. 10.1126/science.7855590, 7855590.
58. Wu J, Grindlay GJ, Bushel P, Mendelsohn L, Allan M. Negative Regulation of the Human ε-Globin Gene by Transcriptional Interference: Role of an Alu Repetitive Element. Mol Cell Biol 1990, 10(3):1209-1216. 360999, 2304465.
59. Bennett EA, Keller H, Mills RE, Schmidt S, Moran JV, Weichenrieder O, Devine SE. Active Alu retrotransposons in the human genome. Genome Res 2008, 18(12):1875-1883. 10.1101/gr.081737.108, 2593586, 18836035.
60. Rikhof B, Corn PG, El-Deiry WS. Caspase 10 levels are increased following DNA damage in a p53-dependent manner. Cancer Biol Ther 2003, 2(6):707-712.
61. Kohany O, Gentles AJ, Hankus L, Jurka J. Annotation, submission and screening of repetitive elements in Repbase: RepbaseSubmitter and Censor. BMC Bioinformatics 2006, 7:474. 10.1186/1471-2105-7-474, 1634758, 17064419.
62. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994, 265(5170):346-355. 10.1126/science.8023157, 8023157.
63. Kitayner M, Rozenberg H, Kessler N, Rabinovich D, Shaulov L, Haran TE, Shakked Z. Structural basis of DNA recognition by p53 tetramers. Mol Cell 2006, 22(6):741-753. 10.1016/j.molcel.2006.05.015, 16793544.
64. Hoh J, Jin S, Parrado T, Edington J, Levine AJ, Ott J. The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci USA 2002, 99(13):8467-8472. 10.1073/pnas.132268899, 124275, 12077306.
65. Dagan T, Sorek R, Sharon E, Ast G, Graur D. AluGene: a database of Alu elements incorporated within protein-coding genes. Nucleic Acids Res 2004, (32 Database):D489-D492. 10.1093/nar/gkh132, 308866, 14681464.
66. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000, 408(6810):307-310. 10.1038/35042675, 11099028.
67. Estève PO, Chin HG, Pradhan S. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc Natl Acad Sci USA 2005, 102(4):1000-1005. 544618, 15657147.
68. Tuncbag N, Kar G, Gursoy A, Keskin O, Nussinov R. Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example. Mol Biosyst 2009, 5(12):1770-1778. 10.1039/b905661k, 19585003.
69. Makalowski W. Genomic scrap yard: how genomes utilize all that junk. Gene 2000, 259(1-2):61-67. 10.1016/S0378-1119(00)00436-4, 11163962.
70. Horvath MM, Wang X, Resnick MA, Bell DA. Divergent evolution of human p53 binding sites: cell cycle versus apoptosis. PLoS Genet 2007, 3(7):e127. 10.1371/journal.pgen.0030127, 1934401, 17677004.
71. Doniger SW, Fay JC. Frequent gain and loss of functional transcription factor binding sites. PLoS Comput Biol 2007, 3(5):e99. 10.1371/journal.pcbi.0030099, 1876492, 17530920.
72. Kapitonov V, Jurka J. The age of Alu subfamilies. J Mol Evol 1996, 42(1):59-65. 10.1007/BF00163212, 8576965.
73. Price AL, Eskin E, Pevzner PA. Whole-genome analysis of Alu repeat elements reveals complex evolutionary history. Genome Res 2004, 14(11):2245-2252. 10.1101/gr.2693004, 525682, 15520288.
74. Jurka J. Repeats in genomic DNA: mining and meaning. Curr Opin Struct Biol 1998, 8(3):333-337. 10.1016/S0959-440X(98)80067-5, 9666329.
75. Jurka J. Repbase Update: a database and an electronic journal of repetitive elements. Trends Genet 2000, 16(9):418-420. 10.1016/S0168-9525(00)02093-X, 10973072.
76. Jurka J, Kapitonov VV, Pavlicek A, Klonowski P, Kohany O, Walichiewicz J. Repbase Update, a database of eukaryotic repetitive elements. Cytogenet Genome Res 2005, 110(1-4):462-467. 10.1159/000084979, 16093699.
77. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series 1999, 41:95-98.
78. Nishihara H, Terai Y, Okada N. Characterization of novel Alu- and tRNA-related SINEs from the tree shrew and evolutionary implications of their origins. Mol Biol Evol 2002, 19(11):1964-1972.
79. Richmond TJ, Davey CA. The structure of DNA in the nucleosome core. Nature 2003, 423(6936):145-150. 10.1038/nature01595, 12736678.
80. Quentin Y. Origin of the Alu family: a family of Alu-like monomers gave birth to the left and the right arms of the Alu elements. Nucleic Acids Res 1992, 20(13):3397-3401. 10.1093/nar/20.13.3397, 312495, 1378589.
81. Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev Genet 2002, 3(5):370-379. 10.1038/nrg798, 11988762.
82. Xing J, Hedges DJ, Han K, Wang H, Cordaux R, Batzer MA. Alu element mutation spectra: molecular clocks and the effect of DNA methylation. J Mol Biol 2004, 344(3):675-682. 10.1016/j.jmb.2004.09.058, 15533437.